Insider · CIK 0001928994
Shriram Revankar
Files at DLB (Dolby Laboratories, Inc.). First filing Aug 26, 2025, latest Nov 24, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
DLB: Dolby Laboratories, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 22Weak | Dolby Laboratories, Inc. | $197k 3,000 shares | -4% | +5% from low-22% from high | |
| 41Moderate | Dolby Laboratories, Inc. | $524k 7,000 shares | -9% | +11% from low-12% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 15, 2025 | DLB Dolby Laboratories, Inc. | AGrant or award Class A Common Stock | +22,617 | $0.00 | $0 | 90,052 | Dec 17, 2025 |
| Dec 15, 2025 | DLB Dolby Laboratories, Inc. | MOption exercise Class A Common Stock | +3,412 | $0.00 | $0 | 93,464 | Dec 17, 2025 |
| Dec 15, 2025 | DLB Dolby Laboratories, Inc. | FTax withholding Class A Common Stock | -4,961 | $67.54 | $335k | 88,503 | Dec 17, 2025 |
| Dec 16, 2025 | DLB Dolby Laboratories, Inc. | FTax withholding Class A Common Stock | -2,285 | $66.62 | $152k | 86,218 | Dec 17, 2025 |
| Dec 15, 2025 | DLB Dolby Laboratories, Inc. | AGrant or award Performance-Based Restricted Stock Unitderivative | +11,308 | $0.00 | $0 | 11,308 | Dec 17, 2025 |
| Dec 15, 2025 | DLB Dolby Laboratories, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +49,800 | $0.00 | $0 | 49,800 | Dec 17, 2025 |
| Dec 15, 2025 | DLB Dolby Laboratories, Inc. | MOption exercise Performance-Based Restricted Stock Unitderivative | -3,412 | $0.00 | $0 | 0 | Dec 17, 2025 |
| Nov 21, 2025 | DLB Dolby Laboratories, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -3,000 | $65.55 | $197k | 67,435 | Nov 24, 2025 |
| Aug 22, 2025 | DLB Dolby Laboratories, Inc. | SOpen-market sale Class A Common Stock | -7,000 | $74.92 | $524k | 70,435 | Aug 26, 2025 |
| May 16, 2025 | DLB Dolby Laboratories, Inc. | FTax withholding Class A Common Stock | -4,329 | $77.24 | $334k | 77,435 | May 20, 2025 |
| Dec 16, 2024 | DLB Dolby Laboratories, Inc. | AGrant or award Class A Common Stock | +18,141 | $0.00 | $0 | 84,777 | Dec 18, 2024 |
| Dec 16, 2024 | DLB Dolby Laboratories, Inc. | FTax withholding Class A Common Stock | -3,364 | $79.18 | $266k | 81,413 | Dec 18, 2024 |
| Dec 16, 2024 | DLB Dolby Laboratories, Inc. | AGrant or award Performance-Based Restricted Stock Unitderivative | +9,070 | $0.00 | $0 | 9,070 | Dec 18, 2024 |
| Dec 16, 2024 | DLB Dolby Laboratories, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +31,890 | $0.00 | $0 | 31,890 | Dec 18, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.